FINWIRES · TerminalLIVE
FINWIRES

Market Chatter: US-based Axiom Biosciences Plans Hong Kong IPO in 2027

By

U.S. biotech firm Axiom Biosciences is planning a Hong Kong initial public offering in 2027, Bloomberg News reported Tuesday, citing CEO Remo Moomiaie-Qajar.

The IPO proceeds will fund clinical trials of Axiom's stem cell therapy for neurological disorders and future clinical development in China. The company is also targeting a secondary U.S. listing at a later stage, Bloomberg reported.

Backed by Asian institutional investors, Axiom is co-developing its lead drug with a South Korean partner and is in talks with several Chinese companies on potential collaborations, the report said.

Axiom Biosciences did not immediately respond to' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Related Articles

Asia

Aedge Group Unit to Buy Commercial Property for SG$7.5 Million

Aedge Group's (SGX:XVG) subsidiary, IPF Investments, exercised an option to acquire a freehold property in Singapore for SG$7.5 million, according to a Monday bourse filing.The property has a land area of around 297.4 square meters and is currently tenanted at a monthly rent of SG$20,000.The acquisition will be funded through a combination of internal resources and bank borrowings and is expected to be completed on or before Oct. 13.

SGX:XVG
Asia

Huadian New Energy's Power Generation Rises 24% in Q2

Huadian New Energy's (SHA:600930) power generation in the second quarter rose 24% year on year to 36.2 billion kilowatt-hours, according to a Shanghai bourse filing on Tuesday.The increase was mainly attributable to the commissioning of additional installed generating capacity, with 2.39 million kilowatts being added during the quarter.For the first half, the power company's power generation climbed 22% to 69.1 billion kWh from a year earlier.The company's shares fell 3% during the morning trade.

SHA:600930
Asia

Giga Device Semiconductor Sees No Reason for Stock Surge; Shares Rise 9%

Giga Device Semiconductor's (HKG:3986, SHA:603986) stock deviated by more than 20% across three straight trading sessions on July 16, 17, and 20, according to a Tuesday filing with the Shanghai bourse.Following an internal investigation and verification with its controlling shareholder and actual controller, the company said it has no undisclosed material information, plans, or negotiations that may have had a significant impact on its stock price.The company's shares jumped 9% recently.

SHA:603986